Expression profile of microRNAs related with viral infectivity, inflammatory response, and immune activation in people living with HIV
Frontiers in Microbiology · 02.03.2023 · 14
DOI: 10.3389/fmicb.2023.1136718 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Microbiology, online erschienen am 02.03.2023. Verfasst von Sara Cuesta-Sancho und 10 weiteren Autor:innen. Beteiligte Einrichtung: Unidad de Enfermedades Infecciosas, Servicio de Medicina Interna, Facultad de Medicina, Hospital Universitario Puerta del Mar, Instituto de Investiga…. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
To evaluate the serum expression of microRNAs (miRNAs) with ability to modulate the human immunodeficiency (HIV) replication or inflammatory status in people living with HIV (PLWH).
Methods
Forty healthy controls and two groups of PLWH were evaluated: (a) Group 1 ( n = 30), patients with detectable viral load at inclusion, analyzed before receiving antiretroviral therapy (ART) and 12 months after initiating it; (b) Group 2 ( n = 55), PLWH with prolonged undetectable viral load. Intestinal barrier disruption (I-FABP) and bacterial translocation (16S rDNA) markers, inflammatory markers such as interleukin (IL)-6 and sCD163, immune activation and expression of specific miRNAs were evaluated.
Results
Serum concentrations of I-FABP, 16S rDNA, IL-6, sCD163 and activated T lymphocytes were increased in PLWH. Serum miR-34a was overexpressed at inclusion and remained elevated after ART. The expression of the remaining miRNAs that modulate HIV infectivity (miR-7, mir-29a, miR-150, and miR-223) was similar in PLWH and controls. Related to miRNAs implicated in inflammation (miR-21, miR-155, and miR-210), significant overexpression were observed in miR-21 and miR-210 levels in untreated PLWH, but levels were restored in those patients treated for a long period.
Conclusion
A sustained overexpression of miR-34a was detected even after prolonged HIV controlled replication. miR-21 and miR-210 can be considered new markers of inflammation with high sensitivity to its modifications.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Unidad de Enfermedades Infecciosas, Servicio de Medicina Interna, Facultad de Medicina, Hospital Universitario Puerta del Mar, Instituto de Investigación e Innovación en Ciencias Biomédicas de Cádiz (INiBICA), Universid…
- Servicio de Microbiología, Facultad de Medicina, Hospital Universitario Puerta del Mar, Instituto de Investigación e Innovación en Ciencias Biomédicas de Cádiz (INiBICA), Universidad de Cádiz, Cádiz, Spain.
- Unidad de Enfermedades Infecciosas, Facultad de Medicina, Hospital Universitario Puerto Real, Instituto de Investigación e Innovación en Ciencias Biomédicas de Cádiz (INiBICA), Universidad de Cádiz, Cádiz, Spain.
Zitieren
APA
Cuesta-Sancho, S., Márquez-Ruiz, D., Illanes-Álvarez, F., Campaña-Gómez, I., Martín-Aspas, A., Trujillo-Soto, M. T., Romero, A., Galán, F., Rodríguez-Iglesias, M., Márquez-Coello, M., & Girón-González, J. A. (2023). Expression profile of microRNAs related with viral infectivity, inflammatory response, and immune activation in people living with HIV. Frontiers in Microbiology, 14. https://doi.org/10.3389/fmicb.2023.1136718
Vancouver
Cuesta-Sancho S, Márquez-Ruiz D, Illanes-Álvarez F, Campaña-Gómez I, Martín-Aspas A, Trujillo-Soto MT, et al. Expression profile of microRNAs related with viral infectivity, inflammatory response, and immune activation in people living with HIV. Frontiers in Microbiology. 2023;14. doi:10.3389/fmicb.2023.1136718
BibTeX
@article{CuestaSancho2023,
author = {Cuesta-Sancho, Sara and Márquez-Ruiz, Denisse and Illanes-Álvarez, Francisco and Campaña-Gómez, Irene and Martín-Aspas, Andrés and Trujillo-Soto, María Teresa and Romero, Alberto and Galán, Fátima and Rodríguez-Iglesias, Manuel and Márquez-Coello, Mercedes and Girón-González, José-Antonio},
title = {Expression profile of microRNAs related with viral infectivity, inflammatory response, and immune activation in people living with HIV},
journal = {Frontiers in Microbiology},
year = {2023},
volume = {14},
doi = {10.3389/fmicb.2023.1136718}
}
EUVIMED